Cargando…
Rituximab for idiopathic and IgG4-related retroperitoneal fibrosis
Retroperitoneal fibrosis (RPF) refers to a fibro-inflammatory lesion in the retroperitoneum, often anterolateral to the aorta. Most cases are due to IgG4-related disease (IgG4-RD) or are idiopathic. RPF can lead to severe morbidity. Treatment strategies remain poorly-defined. We evaluated the effica...
Autores principales: | Wallwork, Rachel, Wallace, Zachary, Perugino, Cory, Sharma, Amita, Stone, John H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211888/ https://www.ncbi.nlm.nih.gov/pubmed/30334947 http://dx.doi.org/10.1097/MD.0000000000012631 |
Ejemplares similares
-
Large vessel involvement by IgG4-related disease
por: Perugino, Cory A., et al.
Publicado: (2016) -
Clinical characteristics of IgG4-related retroperitoneal fibrosis versus idiopathic retroperitoneal fibrosis
por: Wang, Kunkun, et al.
Publicado: (2021) -
Rethinking Ormond’s Disease: “Idiopathic” Retroperitoneal Fibrosis in the Era of IgG4-Related Disease
por: Khosroshahi, Arezou, et al.
Publicado: (2013) -
Rituximab for retroperitoneal fibrosis due to IgG4-related disease: A case report and literature review
por: Almeqdadi, Mohammad, et al.
Publicado: (2018) -
Treatment Response to Idiopathic Retroperitoneal Fibrosis-associated Hydronephrosis With a Focus on IgG4/IgG3 Serum Concentration Ratio
por: Choi, Su Jin, et al.
Publicado: (2021)